Monsanto (MON) announced that it earned $1.2 billion on revenue $4.7 billion for the quarter that ended on February 29. In the same period last year, the company earned $1 billion on revenue of $4.1 billion.
Urban Outfitters Shares Rise After Upgrade by Citigroup
Urban Outfitters (NASDAQ:URBN) shares rose 2.5% this morning after the company was upgraded from neutral to sell by Citigroup.Urban Outfitters is currently above its 50-day moving average (MA) of $28.10 and above its 200-day of $27.28.In the last five trading sessions, the 50-day MA has climbed 0.82% while the 200-day MA has remained constant.
Sales of GM Up 12% For the Month of March
In March, sales of GM rose 12%. Passenger car sales rose 22%, while compact-crossover sales increased at a high of 47% and mid size vehicles were up 38%.In mid-morning trading shares of the company were 22% at $26.18.General Motors (NYSE:GM) has potential upside of 30.7% based on a current price of $26.21 and an average consensus analyst price target of $34.27.
Qualcomm To Pay Shareholders in June
Qualcomm (NASDAQ:QCOM) announced Tuesday that it will pay shareholders $0.25 per share on June 20, an increase from the prior pay out of 21.5 cents per share.In past years, Qualcomm has been gradually raising its dividend.QUALCOMM (NASDAQ:QCOM) has potential upside of 4.5% based on a current price of $68.42 and an average consensus analyst price target of $71.51.
Interview with David Pritchard Co-Founder and Principal of Aequitas Advisors
This is a companion discussion with the other co-founder of Aequitas Advisors David Pritchard. This is more of an explanation of what his company does in respect to the relationship between clients and investment banks
GlaxoSmithKline to Purchase 10 Million Shares of Theravance Inc.
GlaxoSmithKline (NYSE:GSK) announced Monday it plans to purchase 10 million shares of Theravance Inc (NASDAQ:THVRX). for $21.29 a share, an estimates $213 million.GlaxoSmithKline (NYSE:GSK) has potential upside of 14.8% based on a current price of $44.91 and an average consensus analyst price target of $51.56.GlaxoSmithKline is currently below its 50-day moving average (MA) of $44.91 and should find support at its 200-day MA of $43.64.In the last five trading sessions, the 50-day MA has remained constant while the 200-day MA has risen 0.19%.
Analyst Moves: AZO, P
Autozone (AZO) was upgraded today by Goldman Sachs (GS) from neutral to buy with a $435 price target due to higher commerical demand and strong operating leverage. Shares are higher by about one percent.
Daily Dividend Report: ALG, RPM, SSS, QCOM
Alamo Group Incorporated (ALG) maintained its quarterly dividend of 6 cents per share. The dividend is payable April 30, 2012, to shareholders of record at the close of business on April 16, 2012.
Tuesday 4/3 Insider Buying Report: SIG, EPD
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let’s look at a noteworthy recent insider buy.
Tuesday 4/3 Insider Buying Report: HCOM, XPL
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let’s look at two noteworthy recent insider buys.